What is NeoGenomics, Inc.'s Market Cap?

NeoGenomics, Inc.'s Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s Enterprise Value?

NeoGenomics, Inc.'s Enterprise Value is $2.4B, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s Price / Sales?

NeoGenomics, Inc.'s Price / Sales is 2.8×, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s EV / Revenue?

NeoGenomics, Inc.'s EV / Revenue is 3.1×, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s EV / EBITDA?

NeoGenomics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s Revenue (TTM)?

NeoGenomics, Inc.'s Revenue (TTM) is $766.3M, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s Net Income (TTM)?

NeoGenomics, Inc.'s Net Income (TTM) is -$51.9M, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s EBITDA?

NeoGenomics, Inc.'s EBITDA is -$3.0M, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s Diluted EPS (TTM)?

NeoGenomics, Inc.'s Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.

What is NeoGenomics, Inc.'s EBITDA Margin?

NeoGenomics, Inc.'s EBITDA Margin is -0.4%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / SERVICES-TESTING LABORATORIES

NeoGenomics, Inc.

XNAS · usd

SIC 8734 · SERVICES-TESTING LABORATORIES

FIGI BBG001S9DSY4

16.59▲ 0.20 (1.22%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 16.39
Day's Range: 16.07 – 16.76
52-Week Range: 7.06 – 20.15
Volume: 1.4M
Avg Volume: 2.3M

Share Statistics

Shares Outstanding
Employees: 2,500
Exchange: XNAS
Listed: 1996-01-25

Share count as of July 24, 2026

NeoGenomics, Inc. (NEO) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about NeoGenomics, Inc. (NEO)

What is NeoGenomics, Inc.'s Market Cap?: NeoGenomics, Inc.'s Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Enterprise Value?: NeoGenomics, Inc.'s Enterprise Value is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Price / Sales?: NeoGenomics, Inc.'s Price / Sales is 2.8×, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EV / Revenue?: NeoGenomics, Inc.'s EV / Revenue is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EV / EBITDA?: NeoGenomics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Revenue (TTM)?: NeoGenomics, Inc.'s Revenue (TTM) is $766.3M, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Net Income (TTM)?: NeoGenomics, Inc.'s Net Income (TTM) is -$51.9M, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EBITDA?: NeoGenomics, Inc.'s EBITDA is -$3.0M, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Diluted EPS (TTM)?: NeoGenomics, Inc.'s Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EBITDA Margin?: NeoGenomics, Inc.'s EBITDA Margin is -0.4%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · NEOAs-filed SEC (XBRL) data